Clinical Trial Update: Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer [Phase 2]

View source ↗

Summary

Phase II randomized trial assessing neoadjuvant neratinib and/or trastuzumab followed by postoperative trastuzumab in locally advanced HER2-positive breast canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Trastuzumab (trastuzumab)
• neratinib (neratinib)

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-12-06